Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Morgan Stanley’s disclosures are a treasure trove of information on everything from trading Value-at-Risk to the health of its $4T wealth-management franchise. But finding those details inside a 300-page report is tedious. This page curates every filing the firm submits to EDGAR, then layers Stock Titan’s AI so Morgan Stanley SEC filings are explained simply.
Need the latest Morgan Stanley quarterly earnings report 10-Q filing or an Morgan Stanley 8-K material events explained summary? We post them in real time and generate concise AI-powered breakdowns of segment revenue, capital ratios, and liquidity buffers. Curious about management’s trading activity? Our alerts track Morgan Stanley insider trading Form 4 transactions and show Morgan Stanley Form 4 insider transactions real-time, highlighting patterns before they hit the news. When proxy season arrives, the platform pinpoints pay packages inside the Morgan Stanley proxy statement executive compensation section—no more hunting through exhibits.
Professionals use these tools to:
- Compare quarter-over-quarter margins with a click using our Morgan Stanley earnings report filing analysis
- Monitor Morgan Stanley executive stock transactions Form 4 for buy-sell trends
- Read a Morgan Stanley annual report 10-K simplified summary that clarifies risk factors, legal reserves, and capital plans
- Ask natural questions like “understanding Morgan Stanley SEC documents with AI” and receive instant answers
Whether you’re gauging deal pipelines, stress-testing balance sheets, or assessing leadership’s confidence, our AI-powered summaries, expert context, and real-time updates turn raw filings into actionable knowledge—faster than opening a PDF.
SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) filed seven Post-Effective Amendments on Form S-8 to deregister all unsold shares previously registered for issuance under its 2019 employee equity plans. The action follows the closing of its merger with Merck KGaA, Darmstadt, Germany on 1 July 2025, under which SpringWorks became a wholly owned subsidiary of Merck through EMD Holdings Merger Sub, Inc.
The amendments cover the following historical S-8 registrations:
- Reg. Nos. 333-234365, 333-237350, 333-253531, 333-262996, 333-270096, 333-277380 and 333-285076.
- In aggregate, these filings had registered tens of millions of common shares for the 2019 Stock Option & Incentive Plan, the Amended & Restated 2019 Equity Incentive Plan and the 2019 Employee Stock Purchase Plan.
Because the company is now private, SpringWorks has terminated all offerings under these plans. Consistent with undertakings in each registration statement, any securities that remained unsold as of the merger date are withdrawn from registration. The filing is signed on behalf of the company by Secretary Michael MacDougall and relies on Rule 478 of the Securities Act to omit additional signatures.
The amendments are largely administrative, signalling the end of SpringWorks’ status as an independent public issuer and the cessation of share issuance under its legacy equity compensation and ESPP programmes.
Form 144 filing for Etsy, Inc. (ETSY) discloses the planned sale of 1,500 common shares at an estimated aggregate market value of $75,075. The filer intends to execute the transaction on or about 07/01/2025 through UBS Financial Services, Inc. on the NASDAQ exchange.
The same individual—identified by the address "117 Adam Street, Brooklyn, NY 11201"—has already sold 4,500 Etsy shares in the last three months (1,500 shares on each of 04/01/2025, 05/01/2025, and 06/02/2025) for total gross proceeds of $225,140.70.
With 104,282,256 shares outstanding, the new proposed sale represents roughly 0.0014 % of Etsy’s total shares, indicating minimal dilution or ownership impact. No relationship to the issuer or 10b5-1 trading plan details are provided, and the filer affirms no undisclosed material information.
For investors, the filing signals continued, small-scale insider selling; while not material to share count, it may be a sentiment data-point to monitor if selling accelerates or expands in size.
Morgan Stanley Finance LLC, guaranteed by Morgan Stanley (ticker MS), is marketing Worst-of INDU and SPX Dual Directional Market-Linked Notes maturing on August 1, 2030. The structured note allocates exposure to the worst performer of the Dow Jones Industrial Average (INDU) and the S&P 500 Index (SPX). Key economic terms include a 100% upside participation rate and a 100% “absolute return” participation on index declines of up to 20%. Positive index performance is capped at 137-140% of principal (maximum cash payment $1,370-$1,400). If the worst performing index closes below the 80% knock-out level on the single observation date (July 29, 2030), principal is fully at risk; the payment then reflects only the indexed return, potentially below par. The notes do not pay coupons and are not listed on any exchange.
The preliminary estimated value is $938.10 per $1,000 note—roughly 6% below issue price—highlighting built-in fees and hedging costs. Investors face issuer and guarantor credit risk, limited secondary liquidity, tax complexity and valuation determined by Morgan Stanley’s internal models. All payments occur at maturity and depend solely on the closing level of the worst index on the observation date; interim movements are irrelevant. The offering is made under Registration Statement Nos. 333-275587 and 333-275587-01, with pricing set for July 28, 2025.
Amendment No. 25 to Schedule 13D discloses that India-based Tractors & Farm Equipment Ltd (TAFE), TAFE Motors & Tractors Ltd and chair Mallika Srinivasan collectively hold roughly 16.3 % of AGCO’s 74.6 million outstanding shares (≈12.15 million shares). The filing follows a comprehensive settlement signed on 30 Jun 2025 that resets the long-standing strategic relationship between the two companies.
Key agreements
- Cooperation Agreement: imposes a perpetual stand-still: the Reporting Persons will vote in line with AGCO’s Board and will not raise their ownership above the “Ownership Cap” (≈16.3 %) except on defined change-of-control triggers. They must also participate proportionately in future AGCO buybacks.
- Buyback Agreement: AGCO Holding B.V. will sell its 20.7 % stake in TAFE (2.389 million shares) back to TAFE for US$260 million. Completion is pending Indian procedural approvals.
- Intellectual Property Agreement: Exclusive rights to the “Massey Ferguson” brand for tractors in India, Nepal and Bhutan will transfer to TAFE when the Buyback closes.
- Arbitration & Litigation Settlements: All cross-border disputes and brand-related suits will be withdrawn, eliminating legal overhang.
Strategic implications
- AGCO receives US$260 million cash and exits its minority position in TAFE.
- Stable 16 % shareholder alignment reduces near-term takeover risk and supports Board initiatives.
- Brand transfer limits AGCO’s direct exposure to the fast-growing Indian tractor market but clarifies marketing rights.
Offering overview: Morgan Stanley Finance LLC, guaranteed by Morgan Stanley (“MS”), is marketing five-year “Trigger PLUS” structured notes that settle on August 5, 2030. The notes are linked to the worst-performing of three U.S. equity benchmarks -- the S&P 500 (SPX), Nasdaq-100 (NDX) and Russell 2000 (RTY).
- Upside participation: Final payment equals principal plus 160%–175% of any positive performance of the worst index.
- Downside buffer: Principal is repaid in full as long as the worst index has not fallen more than 35 percent (i.e., it remains at or above 65 percent of its initial level) on the single observation date of July 31, 2030.
- Full downside exposure below the threshold: If that 65 percent trigger is breached, repayment equals principal multiplied by the worst index’s percentage return, generating dollar-for-dollar losses and potentially zero recovery.
- No interim coupons, no early call: Investors receive no periodic interest and their return depends solely on the final index levels.
- Credit & liquidity considerations: All cash flows rely on Morgan Stanley’s credit; the notes will not be listed, and MS expects limited secondary trading. The indicative estimated value is $943.40 versus the assumed $1,000 issue price, reflecting embedded fees and hedging costs.
- Key dates: Pricing - July 31, 2025 | Observation - July 31, 2030 | Maturity - August 5, 2030
- CUSIP: 61778NAZ4 | Registration Nos.: 333-275587 / 333-275587-01
Investor take-away: The structure offers leveraged upside and a 35% buffer, but embeds significant risks: (i) worst-of design magnifies downside probability, (ii) principal is unprotected below the trigger, (iii) valuation is below par at issuance, (iv) tax treatment is uncertain, and (v) investors assume MS credit and secondary-market liquidity risk.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering SPUMP40 Contingent Income Memory Buffered Auto-Callable Securities due July 16, 2030. The notes are linked to the S&P U.S. Equity Momentum 40% VT 4% Decrement Index (ticker SPUMP40).
Key commercial terms:
- Contingent coupon: at least 9.0% per annum, paid monthly, with a memory feature if the index closes ≥70% of its initial level on the relevant observation date.
- Automatic early redemption: monthly, starting after the first year, if the index closes at or above 90% of its initial level; investors then receive 100% principal plus accrued coupon.
- Downside exposure: a 15% buffer protects principal for index declines up to 15%. Below that, investors lose 1% of principal for each percentage point decline beyond the buffer, with a maximum loss of 85%.
- Estimated value: approximately $906 versus the $1,000 issue price, reflecting structuring and hedging costs.
- No listing; secondary liquidity will be limited and prices may be volatile.
Primary risks highlighted include (i) no participation in any index appreciation, (ii) reliance on Morgan Stanley’s credit, (iii) potential early redemption that caps income stream, (iv) the index’s limited operating history and 4% decrement drag, (v) uncertain U.S. tax treatment, and (vi) model-based valuation that may differ from secondary market pricing.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering SPUMP40 Contingent Income Memory Buffered Auto-Callable Securities due July 16, 2030. The notes are linked to the S&P U.S. Equity Momentum 40% VT 4% Decrement Index (ticker SPUMP40).
Key commercial terms:
- Contingent coupon: at least 9.0% per annum, paid monthly, with a memory feature if the index closes ≥70% of its initial level on the relevant observation date.
- Automatic early redemption: monthly, starting after the first year, if the index closes at or above 90% of its initial level; investors then receive 100% principal plus accrued coupon.
- Downside exposure: a 15% buffer protects principal for index declines up to 15%. Below that, investors lose 1% of principal for each percentage point decline beyond the buffer, with a maximum loss of 85%.
- Estimated value: approximately $906 versus the $1,000 issue price, reflecting structuring and hedging costs.
- No listing; secondary liquidity will be limited and prices may be volatile.
Primary risks highlighted include (i) no participation in any index appreciation, (ii) reliance on Morgan Stanley’s credit, (iii) potential early redemption that caps income stream, (iv) the index’s limited operating history and 4% decrement drag, (v) uncertain U.S. tax treatment, and (vi) model-based valuation that may differ from secondary market pricing.
Morgan Stanley Finance LLC is marketing Trigger PLUS securities due Aug-1-2030 that are linked to the worst performing of the S&P 500 (SPX), Nasdaq-100 (NDX) and Russell 2000 (RTY) equity indices. Investors will pay $1,000 per note.
Upside: If, on the single observation date (Jul-29-2030), the worst performing index is flat or up, the note pays the principal plus a leveraged return of 148 %-158 % of that positive performance. For example, a 20 % gain would deliver roughly $1,296 per note at the 148 % leverage factor.
Downside protection: Principal is protected only if the worst index has not fallen more than 30 % from its initial level. Should the worst index close below 70 % of its start value, holders are fully exposed to that loss on a 1-for-1 basis, risking total principal.
Key terms: Estimated value is $915.80 (≈8.4 % below issue price), reflecting structuring and hedging costs. The securities are unsecured obligations of Morgan Stanley Finance LLC, guaranteed by Morgan Stanley, and carry both issuer and guarantor credit risk. No periodic coupons are paid, the notes will not be listed, and secondary market liquidity may be limited.
Principal risk factors highlighted include: lack of principal guarantee below the 70 % trigger, single-day observation risk, market and volatility sensitivity, model-based estimated value, potential conflicts of interest as Morgan Stanley acts as calculation agent, and uncertain U.S. tax treatment.
Nature’s Sunshine Products, Inc. (NASDAQ: NATR) has filed a Form 144 indicating the planned disposition of 1,500 common shares through Wells Fargo Clearing Services on or about 01 July 2025. The filing places the aggregate market value of the proposed sale at $22,133.80, based on the prevailing market price at the time of preparation. With 18,350,801 shares outstanding, the contemplated sale represents roughly 0.008% of total shares—an immaterial slice of the company’s equity base.
The seller is identified as the Richard D Moss Revocable Trust (and related individual accounts). The securities were originally acquired on 06 May 2024 as restricted share grants/compensation, meaning the shares are now coming off restriction and becoming eligible for public resale under Rule 144.
Recent selling pattern: The same trust (and Richard D Moss personally) has reported 39,734 shares sold over the last three months, generating cumulative gross proceeds of approximately $479,000 (sum of individual transactions listed). The filing does not cite any material non-public information or trading plan details; the signatory attests to compliance with Rule 144 and the absence of undisclosed adverse information.
For investors, the transaction signals continued insider liquidity activity but, taken alone, is not large enough to affect the float or exert meaningful market pressure. Nevertheless, the frequency of sales may be interpreted as a modestly negative sentiment indicator should the pattern persist.
Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering SPX Market-Linked Notes due August 3, 2028. The notes give investors 100% upside participation in the S&P 500 Index (SPX) but cap total return at 120%-121% of principal. If the index declines, investors still receive the $1,000 principal at maturity, providing full downside protection provided Morgan Stanley meets its obligations.
Key economic terms
- Participation rate: 100%
- Maximum payment: $1,200-$1,210 per note
- Pricing date / Observation date: July 31 2025 / July 31 2028
- Maturity: August 3 2028 (3-year term)
- Estimated value: $971.70 (≈97% of issue price), reflecting dealer charges and hedging costs
- CUSIP: 61778NFT3
The hypothetical payoff table shows that any SPX gain up to 20% yields a proportional increase in redemption value; gains above 20% are capped at the maximum payment. Any negative SPX performance still results in full repayment of principal, but the notes pay no periodic interest.
Material risks highlighted
- Limited upside: returns above 20-21% are forfeited.
- No secondary-market listing; liquidity may be limited and pricing opaque.
- Credit risk: payments depend on Morgan Stanley’s ability to pay; the notes are unsecured and unsubordinated.
- Valuation discount: the $971.70 estimated value is below the $1,000 issue price, implying an initial cost to investors of roughly 2.8-3%.
- Tax: investors may recognize taxable income annually despite no cash distributions.
Prospective buyers should review the preliminary pricing supplement (SEC link provided) and the detailed “Risk Factors” before investing.